论文部分内容阅读
诺华(NOVARTIS)由瑞士的汽巴—嘉基和山德士两大公司于1996年合并而成,其核心业务集中在医药保健、农业和营养三大领域,在全球所有大公司中排名第11位(按市场价值计算)。 北京诺华制药有限公司是NOVARTIS在中国建立的唯一一家制药合资企业,1987年与北京市医药总公司、北京第三制药厂合资,于1993年建成投产。其知名品牌非甾体抗炎药扶他林片剂连续15年居世界销量第一,在中国获NSAIDs市场销量第二;扶他林乳胶剂占
Novartis (NOVARTIS) was formed by the merger of Ciba-Grand and Sandoz in Switzerland in 1996. Its core business is concentrated in three areas: pharmaceuticals, health, agriculture and nutrition. It ranks 11th among all major companies in the world. Bit (calculated by market value). Beijing Novartis Pharmaceutical Co., Ltd. is the only pharmaceutical joint venture established by NOVARTIS in China. In 1987, it was a joint venture with Beijing Pharmaceutical Corporation and Beijing No. 3 Pharmaceutical Factory. It was completed and put into operation in 1993. Its famous brand of non-steroidal anti-inflammatory drugs, fulloline tablets, ranks first in the world for 15 consecutive years, second in sales in NSAIDs market in China, and is supported by emulsions of valsartan.